Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reversibility of Brain Glucose Transport and Metabolism in T2DM: an Intervention Study

NCT04283617 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT04283617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04283617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reversibility of Brain Glucose Transport and Metabolism in T2DM: an Intervention Study
Lead sponsor
Yale University
Phase
Not applicable
Overall status
Withdrawn
Start date
October 12, 2021
Completion date
March 31, 2024
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabete type 2